CNMD: Conmed Corp. Company Profile & Statistics

About

CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.

Info & Links

CEO

Curt R. Hartman

Headquarters

11311 CONCEPT BOULEVARD
LARGO, FL 33773, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

447

Employees

4,000

Conmed Corp. Statistics

Valuation Measures

Market Capitalization²

2.12B

Enterprise Value

3.02B

Enterprise Value/EBITDA(ttm)

10.96

Price to Earnings Ratio(ttm)

18.04

Price to Sales(ttm)

1.68

Price to Book(mrq)

2.32

Price to Cash(ytd)

11.56

Profitability

Gross Margin(ttm)

55.65%

Operating Margin(ttm)

9.41%

Profit Margin(ttm)

10.23%

Return on Equity(ttm)

13.84%

Return on Invested Capital(ttm)

7.14%

Return on Assets(ttm)

5.26%

Income Statement

Revenue(ttm)

1.29B

Revenue Per Share(ttm)

41.70

Gross Profit(ttm)

716.86M

EBITDA(ttm)³

275.62M

Net Income Available to Common(ttm)

131.74M

Diluted EPS(ttm)

4.21

Share Statistics

Beta (5Y Monthly)

1.46

52-Week Change

-37.90%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

30.89M

Dividend Yield

1.14%

Float⁴

28.79M

% Held by Insiders

6.80%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

38.47M

Total Cash Per Share(mrq)

1.25

Total Debt(mrq)

940.81M

Total Debt/Equity(mrq)

100.85%

Current Ratio(mrq)

2.27%

Quick Ratio(mrq)

1.06%

Book Value Per Share(mrq)

30.21

Cash Flow

Operating Cash Flow Per Share(ytd)

3.97

Free Cash Flow(ytd)

114.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CNMD

Conmed Corp.

Conmed Corp. Profile